Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter R Hansen

Showing results (41-50 of 84) with videos related to

Pageof 9
Sort By:
Pharmacogenetics and Genomics|January 14, 2016
Prognostic impact of carboxylesterase 1 gene variants in patients with congestive heart failure treated with angiotensin-converting enzyme inhibitorsKarl E Nelveg-Kristensen, Majbritt B Madsen, Christian Torp-Pedersen, et al.
Journal of Interventional Cardiology|December 24, 2010
Intracoronary compared to intravenous bolus abciximab during primary percutaneous coronary intervention in ST-segment Elevation Myocardial Infarction (STEMI) patients reduces 30-day mortality and target vessel revascularization: a randomized trialAllan Iversen, Ulrik Abildgaard, Anders Galloe, et al.
Echocardiography (Mount Kisco, N.Y.)|December 10, 2017
Coronary microvascular dysfunction and myocardial contractile reserve in women with angina and no obstructive coronary artery diseaseMarie M Michelsen, Adam Pena, Naja D Mygind, et al.
Diabetes Care|November 2, 2011
Vitamin D levels and asymptomatic coronary artery disease in type 2 diabetic patients with elevated urinary albumin excretion rateChristel Joergensen, Henrik Reinhard, Anne Schmedes, et al.
The Journal of Invasive Cardiology|December 25, 2010
Impact of abciximab in diabetic patients with acute coronary syndrome who undergo percutaneous coronary intervention: results from a high-volume, single-center registryAllan Z Iversen, Sune H Pedersen, Christian Joens, et al.
Circulation. Cardiovascular Interventions|May 25, 2016
Influence of Septal Thickness on the Clinical Outcome After Alcohol Septal Alation in Hypertrophic CardiomyopathyMorten K Jensen, Linda Jacobsson, Vibeke Almaas, et al.
Journal of Electrocardiology|September 11, 2009
Reference values of electrocardiogram repolarization variables in a healthy populationChristian Haarmark, Claus Graff, Mads P Andersen, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
NSAIDs are associated with increased risk of atrial fibrillation in patients with prior myocardial infarction: a nationwide studyAnne-Marie Schjerning Olsen, Emil L Fosbøl, Jannik Pallisgaard, et al.
The American Journal of Cardiology|September 18, 2012
Usefulness of soluble urokinase plasminogen activator receptor to predict repeat myocardial infarction and mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous interventionStig Lyngbæk, Jacob L Marott, Daniél V Møller, et al.
BMC Neurology|November 1, 2013
Temporal trends in stroke admissions in Denmark 1997-2009Malene Nøhr Demant, Charlotte Andersson, Ole Ahlehoff, et al.
Pageof 9

Showing results (41-50 of 84) with videos related to

Sort By:
Pageof 9
Pharmacogenetics and Genomics|January 14, 2016
Prognostic impact of carboxylesterase 1 gene variants in patients with congestive heart failure treated with angiotensin-converting enzyme inhibitorsKarl E Nelveg-Kristensen, Majbritt B Madsen, Christian Torp-Pedersen, et al.
Journal of Interventional Cardiology|December 24, 2010
Intracoronary compared to intravenous bolus abciximab during primary percutaneous coronary intervention in ST-segment Elevation Myocardial Infarction (STEMI) patients reduces 30-day mortality and target vessel revascularization: a randomized trialAllan Iversen, Ulrik Abildgaard, Anders Galloe, et al.
Echocardiography (Mount Kisco, N.Y.)|December 10, 2017
Coronary microvascular dysfunction and myocardial contractile reserve in women with angina and no obstructive coronary artery diseaseMarie M Michelsen, Adam Pena, Naja D Mygind, et al.
Diabetes Care|November 2, 2011
Vitamin D levels and asymptomatic coronary artery disease in type 2 diabetic patients with elevated urinary albumin excretion rateChristel Joergensen, Henrik Reinhard, Anne Schmedes, et al.
The Journal of Invasive Cardiology|December 25, 2010
Impact of abciximab in diabetic patients with acute coronary syndrome who undergo percutaneous coronary intervention: results from a high-volume, single-center registryAllan Z Iversen, Sune H Pedersen, Christian Joens, et al.
Circulation. Cardiovascular Interventions|May 25, 2016
Influence of Septal Thickness on the Clinical Outcome After Alcohol Septal Alation in Hypertrophic CardiomyopathyMorten K Jensen, Linda Jacobsson, Vibeke Almaas, et al.
Journal of Electrocardiology|September 11, 2009
Reference values of electrocardiogram repolarization variables in a healthy populationChristian Haarmark, Claus Graff, Mads P Andersen, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|August 18, 2016
NSAIDs are associated with increased risk of atrial fibrillation in patients with prior myocardial infarction: a nationwide studyAnne-Marie Schjerning Olsen, Emil L Fosbøl, Jannik Pallisgaard, et al.
The American Journal of Cardiology|September 18, 2012
Usefulness of soluble urokinase plasminogen activator receptor to predict repeat myocardial infarction and mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous interventionStig Lyngbæk, Jacob L Marott, Daniél V Møller, et al.
BMC Neurology|November 1, 2013
Temporal trends in stroke admissions in Denmark 1997-2009Malene Nøhr Demant, Charlotte Andersson, Ole Ahlehoff, et al.
Pageof 9